Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer-Reference-Cited by-同舟云学术

Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer

Published:2019-04-23 Issue: Volume:123 Page:36-42
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Ranasinghe Weranja K.B.¹²^ORCID,Williams Scott³,Ischia Joseph¹²,Wetherell David¹,Baldwin Graham²,Shulkes Arthur²,Sengupta Shomik¹²⁴⁵^ORCID,Bolton Damien¹²,Patel Oneel²

Affiliation:

1. Department of Urology; Austin Health; Heidelberg Vic. Australia

2. Department of Surgery; University of Melbourne; Heidelberg Vic. Australia

3. Peter MacCallum Cancer Institute; Parkville Vic. Australia

4. Department of Urology; Eastern Health; Box Hill Vic Australia

5. Eastern Health Clinical School; Monash University; Box Hill Vic Australia

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14709/fullpdf

Reference33 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Developments in external beam radiotherapy for prostate cancer;Lumen;Urology,2013

3. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer;Ong;BJU Int,2017

4. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review;Selvin;Arch Intern Med,2008

5. Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies;Yu;PLoS ONE,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of metformin on the prognosis of chemoradiotherapy cancer patients: a systematic review and meta-analysis of randomized controlled trials and cohort studies;2023-03-16

2. Targeting lipid metabolism in metastatic prostate cancer;Therapeutic Advances in Medical Oncology;2023-01

3. Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies;Medicine;2022-12-09

4. Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805;The Prostate;2022-05-10

5. Metformin mitigates PLCε gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration‑resistant prostate cancer xenograft models;Oncology Letters;2021-08-08